Pirepemat
Modify Date: 2024-01-14 16:18:16
Pirepemat structure
|
Common Name | Pirepemat | ||
|---|---|---|---|---|
| CAS Number | 1227638-29-0 | Molecular Weight | 213.22 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 276.2±40.0 °C at 760 mmHg | |
| Molecular Formula | C11H13F2NO | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 120.8±27.3 °C | |
Use of PirepematPirepemat (IRL752) is a corticalpreferring catecholamine- and cognition-promoting agent. Pirepemat (IRL752) is used for the study of Parkinson's disease[1][2]. |
| Name | Irl-752 |
|---|---|
| Synonym | More Synonyms |
| Description | Pirepemat (IRL752) is a corticalpreferring catecholamine- and cognition-promoting agent. Pirepemat (IRL752) is used for the study of Parkinson's disease[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | IRL752 displayed its highest in vitro affinities for 5-HT and NA-related targets[2]. |
| In Vivo | IRL752 (3.7-100 µmol/kg, s.c.) has no significant effect on acute hyper-dopaminergic or hypo-glutamatergic motor responses, but reversed deficits resulting from hypomonoaminergic function[2]. Animal Model: Normal rats[2]. Dosage: 3.7-100 µmol/kg. Administration: s.c., 30 min prior to testing. Result: Induced dose-dependent and regio-selective alterations in brain monoamine transmission indices and gene expression. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 276.2±40.0 °C at 760 mmHg |
| Molecular Formula | C11H13F2NO |
| Molecular Weight | 213.22 |
| Flash Point | 120.8±27.3 °C |
| Exact Mass | 213.096527 |
| LogP | 1.01 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.515 |
| 3-(2,3-Difluorophenyl)-3-methoxypyrrolidine |
| Irl-752 |
| Pyrrolidine, 3-(2,3-difluorophenyl)-3-methoxy- |